• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

候选血清生物标志物在意识障碍急性后期和慢性期的预后作用:一项初步研究。

The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary Study.

作者信息

Formisano Rita, D'Ippolito Mariagrazia, Giustini Marco, Catani Sheila, Mondello Stefania, Piccolino Iliana, Iannuzzi Filomena, Wang Kevin K, Hayes Ronald L

机构信息

Neurorehabilitation 2, Post-Coma Unit, IRCCS Fondazione Santa Lucia, 00179 Rome, Italy.

Environmental and Social Epidemiology Unit, National Institute of Health, 00161 Rome, Italy.

出版信息

Brain Sci. 2024 Feb 29;14(3):239. doi: 10.3390/brainsci14030239.

DOI:10.3390/brainsci14030239
PMID:38539627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10968965/
Abstract

INTRODUCTION

Serum biomarkers, such as Neurofilament Light (NF-L), Glial Fibrillary Acidic Protein (GFAP), Ubiquitin C-terminal Hydrolase (UCH-L1), and Total-tau (T-Tau) have been proposed for outcome prediction in the acute phase of severe traumatic brain injury, but they have been less investigated in patients with prolonged DoC (p-DoC).

METHODS

We enrolled 25 p-DoC patients according to the Coma Recovery Scale-Revised (CRS-R). We identified different time points: injury onset (t), first blood sampling at admission in Neurorehabilitation (t), and second blood sampling at discharge (t). Patients were split into improved (improved level of consciousness from t to t) and not-improved (unchanged or worsened level of consciousness from t to t).

RESULTS

All biomarker levels decreased over time, even though each biomarker reveals typical features. Serum GFAP showed a weak correlation between t and t ( = 0.001), while no correlation was observed for serum NF-L ( = 0.955), UCH-L1 ( = 0.693), and T-Tau ( = 0.535) between t and t. Improved patients showed a significant decrease in the level of NF-L ( = 0.0001), UCH-L1 ( = 0.001), and T-Tau ( = 0.002), but not for serum GFAP ( = 0.283). No significant statistical differences were observed in the not-improved group.

CONCLUSIONS

A significant correlation was found between the level of consciousness improvement and decreased NF-L, UCH-L1, and T-Tau levels. Future studies on the association of serum biomarkers with neurophysiological and neuroimaging prognostic indicators are recommended.

摘要

引言

血清生物标志物,如神经丝轻链(NF-L)、胶质纤维酸性蛋白(GFAP)、泛素羧基末端水解酶(UCH-L1)和总tau蛋白(T-Tau),已被提出用于预测重度创伤性脑损伤急性期的预后,但在持续性植物状态(p-DoC)患者中的研究较少。

方法

我们根据修订的昏迷恢复量表(CRS-R)纳入了25例p-DoC患者。我们确定了不同的时间点:受伤时(t)、神经康复入院时首次采血时(t)和出院时第二次采血时(t)。患者被分为意识改善组(从t到t意识水平改善)和未改善组(从t到t意识水平无变化或恶化)。

结果

尽管每种生物标志物都有其典型特征,但所有生物标志物水平均随时间下降。血清GFAP在t和t之间显示出弱相关性(=0.001),而血清NF-L(=0.955)、UCH-L1(=0.693)和T-Tau(=0.535)在t和t之间未观察到相关性。意识改善的患者NF-L(=0.0001)、UCH-L1(=0.001)和T-Tau(=0.002)水平显著下降,但血清GFAP水平未下降(=0.283)。未改善组未观察到显著的统计学差异。

结论

意识改善水平与NF-L、UCH-L1和T-Tau水平降低之间存在显著相关性。建议未来开展关于血清生物标志物与神经生理和神经影像预后指标关联的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235b/10968965/dcb36fa00176/brainsci-14-00239-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235b/10968965/3bd58b5f744a/brainsci-14-00239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235b/10968965/dcb36fa00176/brainsci-14-00239-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235b/10968965/3bd58b5f744a/brainsci-14-00239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235b/10968965/dcb36fa00176/brainsci-14-00239-g002.jpg

相似文献

1
The Prognostic Role of Candidate Serum Biomarkers in the Post-Acute and Chronic Phases of Disorder of Consciousness: A Preliminary Study.候选血清生物标志物在意识障碍急性后期和慢性期的预后作用:一项初步研究。
Brain Sci. 2024 Feb 29;14(3):239. doi: 10.3390/brainsci14030239.
2
Effect of Player Position on Serum Biomarkers during Participation in a Season of Collegiate Football.参与大学橄榄球赛季时球员位置对血清生物标志物的影响。
J Neurotrauma. 2022 Oct;39(19-20):1339-1348. doi: 10.1089/neu.2022.0083. Epub 2022 Sep 1.
3
Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.胶质纤维酸性蛋白和泛素羧基末端水解酶-L1作为创伤性脑损伤的预后预测指标
World Neurosurg. 2016 Mar;87:8-20. doi: 10.1016/j.wneu.2015.10.066. Epub 2015 Nov 10.
4
Omega-3 Fatty Acids and Vitamin D Decrease Plasma T-Tau, GFAP, and UCH-L1 in Experimental Traumatic Brain Injury.ω-3脂肪酸和维生素D可降低实验性创伤性脑损伤中的血浆总tau蛋白、胶质纤维酸性蛋白和泛素羧基末端水解酶L1水平。
Front Nutr. 2021 Jun 4;8:685220. doi: 10.3389/fnut.2021.685220. eCollection 2021.
5
Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.在亚急性和慢性创伤性脑损伤中,NfL、tau、GFAP 和 UCH-L1 的时间进程和诊断效用。
Neurology. 2020 Aug 11;95(6):e623-e636. doi: 10.1212/WNL.0000000000009985. Epub 2020 Jul 8.
6
Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.神经元和神经胶质标志物与严重创伤性脑损伤患者的计算机断层扫描结果和预后的相关性不同:一项病例对照研究。
Crit Care. 2011 Jun 24;15(3):R156. doi: 10.1186/cc10286.
7
Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.儿童严重创伤性脑损伤后血清泛素 C 末端水解酶-L1 和 145 kDa αII-血影蛋白降解产物的时间反应曲线
J Neurosurg Pediatr. 2018 Oct;22(4):369-374. doi: 10.3171/2018.4.PEDS17593. Epub 2018 Jun 29.
8
The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.创伤性脑损伤后第一周内胶质纤维酸性蛋白和泛素 C 末端水解酶-L1 的水平:与临床和影像学结果的相关性
Neurosurgery. 2016 Sep;79(3):456-64. doi: 10.1227/NEU.0000000000001226.
9
High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19.神经丝轻链、胶质纤维酸性蛋白、tau 蛋白和泛素羧基末端水解酶-L1 水平升高可能是急性 COVID-19 严重程度和致死性的潜在预测生物标志物。
Mol Neurobiol. 2024 Jun;61(6):3545-3558. doi: 10.1007/s12035-023-03803-z. Epub 2023 Nov 24.
10
Acute Effects of Sport-Related Concussion on Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase L1, Total Tau, and Neurofilament Light Measured by a Multiplex Assay.运动相关性脑震荡对血清神经丝轻链、胶质纤维酸性蛋白、泛素羧基末端水解酶 L1 和总 tau 的急性影响的多重分析检测。
J Neurotrauma. 2020 Jul 1;37(13):1537-1545. doi: 10.1089/neu.2019.6831. Epub 2020 Mar 13.

引用本文的文献

1
ApoE: The Non-Protagonist Actor in Neurological Diseases.载脂蛋白 E:神经疾病中的非主角演员。
Genes (Basel). 2024 Oct 30;15(11):1397. doi: 10.3390/genes15111397.

本文引用的文献

1
The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury.变革者:UCH-L1 和 GFAP 为基础的血液检测成为首个上市的用于轻度创伤性脑损伤的体外诊断测试。
Expert Rev Mol Diagn. 2024 Jan-Feb;24(1-2):67-77. doi: 10.1080/14737159.2024.2306876. Epub 2024 Jan 31.
2
Peripheral blood BDNF and soluble CAM proteins as possible markers of prolonged disorders of consciousness: a pilot study.外周血脑源性神经营养因子和可溶性细胞黏附分子蛋白作为意识障碍迁延的可能标志物:一项初步研究。
Sci Rep. 2024 Jan 3;14(1):341. doi: 10.1038/s41598-023-50581-8.
3
Investigating microRNAs as biomarkers in disorders of consciousness: a longitudinal multicenter study.
探讨意识障碍中 microRNAs 作为生物标志物:一项纵向多中心研究。
Sci Rep. 2023 Oct 27;13(1):18415. doi: 10.1038/s41598-023-45719-7.
4
Cerebrospinal Fluid and Blood Biomarkers in Patients with Post-Traumatic Disorders of Consciousness: A Scoping Review.创伤后意识障碍患者的脑脊液和血液生物标志物:一项范围综述
Brain Sci. 2023 Feb 20;13(2):364. doi: 10.3390/brainsci13020364.
5
An innovative approach for the evaluation of prolonged disorders of consciousness using NF-L and GFAP biomarkers: a pivotal study.使用 NF-L 和 GFAP 生物标志物评估延长的意识障碍的创新方法:一项关键研究。
Sci Rep. 2022 Nov 2;12(1):18446. doi: 10.1038/s41598-022-21930-w.
6
Traumatic brain injury: progress and challenges in prevention, clinical care, and research.创伤性脑损伤:预防、临床护理和研究方面的进展和挑战。
Lancet Neurol. 2022 Nov;21(11):1004-1060. doi: 10.1016/S1474-4422(22)00309-X. Epub 2022 Sep 29.
7
Blood Biomarkers in Brain Injury Medicine.脑损伤医学中的血液生物标志物
Curr Phys Med Rehabil Rep. 2022 Feb 26;2022. doi: 10.1007/s40141-022-00343-w.
8
Post-acute blood biomarkers and disease progression in traumatic brain injury.创伤性脑损伤的急性后期血液生物标志物与疾病进展。
Brain. 2022 Jun 30;145(6):2064-2076. doi: 10.1093/brain/awac126.
9
Blood-based traumatic brain injury biomarkers - Clinical utilities and regulatory pathways in the United States, Europe and Canada.基于血液的创伤性脑损伤生物标志物 - 在美国、欧洲和加拿大的临床应用和监管途径。
Expert Rev Mol Diagn. 2021 Dec;21(12):1303-1321. doi: 10.1080/14737159.2021.2005583. Epub 2021 Nov 29.
10
Traumatic Brain Injury and Risk of Neurodegenerative Disorder.创伤性脑损伤与神经退行性疾病风险
Biol Psychiatry. 2022 Mar 1;91(5):498-507. doi: 10.1016/j.biopsych.2021.05.025. Epub 2021 Jun 2.